产品名称:Human Siglec-8 Antibody (Lirentelimab, Research Use)
产品编号:NBR-0083
针对靶点:Siglec-8
抗体药商品名:Lirentelimab
抗体药描述:Lirentelimab (sold under the brand name AK002) is a humanized nonfucosylated monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). In a randomized clinical trial, lirentelimab was found to improve eosinophil counts and symptoms in individuals with eosinophilic gastritis and duodenitis.